Technical Analysis for TNGX - Tango Therapeutics

Grade Last Price % Change Price Change
D 3.26 -2.69% -0.09
TNGX closed down 2.69 percent on Thursday, February 6, 2025, on 40 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
Stochastic Reached Overbought Strength 0.00%
Weak + Overbought Other 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
20 DMA Support Bullish -2.69%
Crossed Above 50 DMA Bullish -2.69%
Expansion Pivot Buy Setup Bullish Swing Setup -2.69%
Pocket Pivot Bullish Swing Setup -2.69%
Crossed Above 20 DMA Bullish 7.24%
Pocket Pivot Bullish Swing Setup 7.24%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 10 hours ago
Expansion Pivot Buy Entry about 12 hours ago
Rose Above Previous Day's High about 12 hours ago
Down 1% about 12 hours ago
Up 1% about 12 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Biology Treatment Of Cancer Tumor Genetics Medical Genetics Applied Genetics Synthetic Lethality Oncogenomics

Is TNGX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Comments

Indicators

Indicator Value
52 Week High 12.8
52 Week Low 2.585
Average Volume 1,047,045
200-Day Moving Average 6.78
50-Day Moving Average 3.19
20-Day Moving Average 3.01
10-Day Moving Average 3.10
Average True Range 0.24
RSI (14) 54.75
ADX 12.88
+DI 22.68
-DI 15.00
Chandelier Exit (Long, 3 ATRs) 2.92
Chandelier Exit (Short, 3 ATRs) 3.31
Upper Bollinger Bands 3.36
Lower Bollinger Band 2.66
Percent B (%b) 0.86
BandWidth 23.27
MACD Line -0.02
MACD Signal Line -0.07
MACD Histogram 0.052
Fundamentals Value
Market Cap 350.18 Million
Num Shares 107 Million
EPS -1.15
Price-to-Earnings (P/E) Ratio -2.83
Price-to-Sales 7.06
Price-to-Book 1.34
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.56
Resistance 3 (R3) 3.58 3.49 3.51
Resistance 2 (R2) 3.49 3.42 3.49 3.49
Resistance 1 (R1) 3.38 3.37 3.34 3.36 3.48
Pivot Point 3.29 3.29 3.27 3.29 3.29
Support 1 (S1) 3.18 3.22 3.14 3.16 3.04
Support 2 (S2) 3.09 3.17 3.09 3.03
Support 3 (S3) 2.98 3.09 3.01
Support 4 (S4) 2.96